Max Robotics — Global Service Robot Directory + US Certification

About

Yu-pei Zhao is a leading figure in the advancement of robotic hepatopancreatobiliary surgery, with a focused expertise in minimally invasive techniques for complex pancreatic and endocrine tumors. Dr. Zhao’s major contributions center on establishing the safety, feasibility, and efficacy of the Da Vinci robotic system for pancreatic procedures, most notably through co-authoring the landmark "International consensus statement on robotic pancreatic surgery" (2019, 20 citations). This work helped standardize a rapidly evolving field, addressing critical controversies around cost-effectiveness and clinical outcomes. On a practical level, Dr. Zhao has pioneered the combination of intraoperative ultrasonography with robotic surgery for precise localization and enucleation of insulinomas, as demonstrated in a single-center study of 50 cases (2016, 4 citations). This work showcases a tangible achievement in reducing surgical invasiveness while improving tumor detection. With a career dedicated to pushing the boundaries of robotic-assisted precision, Dr. Zhao’s research provides essential guidance for surgeons adopting these technologies, directly impacting patient recovery and surgical safety in pancreatic oncology.